2CUREX Share Price Performance
SEK 1.33
0.87 (191.67%)
Price SEK 1.33
Share Pricen/a
2cureX AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
2CUREX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
2cureX AB (publ) Key Details
Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
Feb 26, 2026
- -1.05
- -386.18%
- -1,333.30%
- 0%
About 2CUREX
- Founded
- 2006
- Employees
- 14
- CEO
- WebsiteView website
2cureX AB (publ) operates as a medtech company in Europe. The company’s principal product is IndiTreat, an IVD test, which helps to predict cancer patient’s response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. In addition, the company offers research and consulting services. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.
